Catherine Lai, Thomas Greenwood, E Paul Wileyto, Nisha Singh, Ashlena Livingston, Amanda Lopez, Selina Luger, Alexander Perl, Ximena Jordan Bruno, Elizabeth Hexner, Shannon R. McCurdy, Saar Gill, Gary Okano, Ali McBride, Carmelo Alonso, Keith Pratz IL18-armored CAR T cells in relapsed/refractory B cell acute lymphoblastic leukemia , American Society of Hematology Annual Meetings, Orlando, FL., 146: 2025,812
Catherine Lai, Thomas Greenwood, E Paul Wileyto, Nisha Singh, Ashlena Livingston, Amanda Lopez, Selina Luger, Alexander Perl, Ximena Jordan Bruno, Elizabeth Hexner, Shannon R. McCurdy, Saar Gill, Gary Okano, Ali McBride, Carmelo Alonso, Keith Pratz Age-ing study: A prospective evaluation of geriatric, patient-reported and frailty assessments to predict outcomes in older adults with acute myeloid leukemia , American Society of Hematology Annual Meetings, Orlando, FL., 146: 2025,2843
Pashna Munshi, Tao Wang, Shannon R. McCurdy, Rajneesh Nath, Cuyler Huffman, Nosha Farhadfar, Zachariah Defilipp, Pooja Khandelwal, Wael Saber, Stephen Spellman, Najla El Jurdi, Stephanie Lee, Zheng Zhou Post-transplant cyclophosphamide based GVHD prophylaxis in HLA-matched related and unrelated donor hematopoietic cell transplantation in adults with hematologic malignancies undergoing myeloablative conditioning: A CIBMTR analysis of 8,272 participants. , American Society of Hematology Annual Meetings, Orlando, FL. , 146(931): 2025
Nikita Dave, Shannon Gier, Marni Kessler, Miguel Rodriguez, Stefan Barta, Elise Chong, Adam Cohen, Noelle Frey, Saar Gill, Shannon Heck, Elizabeth Hexner, Nasheed Hossain, Shivani Kapur, Daniel Landsburg, Alison Loren, Selina Luger, Mary Ellen Martin, Pashna Munshi, Sunita Dwivedy Nasta, Alexander Perl, David Porter, Stephen Schuster, Edward Stadtmauer, Sandra Susanibar-Adaniya, Jakub Svoboda, Abby Togliatii, Dan Vogl, Adam Waxman, Daniel Wu, Shannon R. McCurdy Fried's frailty phenotype predicts survival in pts with relapsed/refractory lymphoma or myeloma undergoing chimeric antigen receptor T-cell therapy–a prospective, observational Study , American Society of Hematology Annual Meetings, Orlando, FL., 146: 2025,7189
Andrew S Artz, Brent R Logan, Wael Saber, Nancy Geller, Anna Bellach, Jianqun Kou, William A Wood, John McCarty, Thomas G Knight, Lyndsey Runaas, Laura Johnston, Jeremy D Walston, Ryotaro Nakamura, Asmita Mishra, Joseph Uberti, Parastoo B Dahi, Jennifer N Saultz, Shannon R McCurdy, Lawrence E Morris Jr, Philip Imus, William J Hogan, Kalyan V Nadiminti, Vijayaraj R Bhatt, Rebecca L Olin, Joseph E Maakaron, Ronald M Sobecks, Sarah A Wall, Deborah Mattila, Bailey Protz, Steven M Devine, Mary M Horowitz, Mohamed L Sorror CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study , Blood Adv: 2025
Shannon R. McCurdy, Scott R. Solomon, Brian C. Shaffer, Meilun He, Yung-Tsi Bolon, Amanda G. Blouin, Alla Keyzner, Francisco A. Socola, Uroosa Ibrahim, Jun Zou, Hana Safah, Nakhle Saba, Shahinaz Gadalla, Miguel-Angel Perales, Sophie Paczesny, Steven G.E. Marsh, Effie W. Petersdorf, Tao Wang, Stephanie J. Lee, Ephraim J. Fuchs Post-Transplant Cyclophosphamide Improves Survival in HLA-DPB1 Mismatched Unrelated Donor Allogeneic Transplantation , Journal of Transplantation and Cellular Therapy: 2025
Jimenez Jimenez AM, Spellman SR, Politikos I, McCurdy SR, Devine SM, Malki MMA, Bolon YT, Lee SJ, Dehn J, Pidala J, Maiers M, Askar M, Malmberg C, Auletta JJ, Stefanski H, Broglie L, Qayed M, Horwitz M, Wilder JS, Gooptu M, Mehta RS, Fernandez-Viña M, Shaw BE, Shaffer BC. Allogeneic Hematopoietic Cell Donor Selection: Contemporary Guidelines from the NMDP/CIBMTR , Transplant Cell Ther: 2025
Sorror ML, Saber W, Logan B, Geller N, Bellach A, Kou J, Wood W, McCarty JM, Knight TG, Runaas L, Johnston L, Walston J, Nakamura R, Jarrett L, Mishra A, Uberti J, Dahi PB, Saultz JN, McCurdy SR, Morris LE, Imus PH, Hogan WJ, Nadiminti K, Bhatt VR, Olin R, Maakaron J, Sobecks R, Wall SA, Mattila D, Protz B, Devine SM, Horowitz MM, Artz AS. Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704 , Blood Adv, 9: 2025,3268-3280
Mehta RS, Choe H, Saultz J, Gong Z, Sharma P, Al-Juhaishi T, Petitto GS, Lazaryan A, Singh A, Xue E, Dimitrova D, Hyder M, McCurdy S, Im A, Huber B, Aljawai YM, Kanakry J, Milano F, Kanakry CG. Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell Transplantation , Am J Hematol: 2025
Munshi PN, Olin RL, Wall S, McCurdy SR, Al-Juhaishi T, Baker J, Bhatt VR, Chokr N, Dahi P, DeFilipp Z, Espinoza-Gutarra M, Farhan S, Gowda L, Hamilton BK, Inamoto Y, Jayani R, Kharfan-Dabaja MA, Lin R, Meyers G, Mishra A, Murthy HS, Nawas M, Rosko AE, Ruiz M, Sorror ML, Sung AD, Carpenter PA, Hamadani M, Artz AS. US Geriatric Assessment Practices for Older Adults Undergoing Hematopoietic Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy: An American Society for Transplantation and Cellular Therapy Physician Survey from the Aging Special Interest Group and Committee on Practice Guidelines , Transplant Cell Ther: 2025
